Alessandro Pinto, Ph.D., currently serves as Associate Director of Product at NuProbe. He received his Ph.D. in chemical engineering from the Rovira I Virgili University. Prior to joining NuProbe, he worked as a Postdoctoral Researcher at University of Basque Country and a Research Scientist at Rice University, with a focus on cancer diagnostics and next-generation sequencing technologies. His work in academia led to 12 peer-reviewed publications, 4 patent families, and 2 book chapters.
Clinical & Research Tools Showcase:
NuProbe is a cutting-edge genomics and molecular diagnostics company with revolutionary technologies to improve the analytical sensitivity of DNA disease biomarkers.
Rapid Custom Development Program for Oncology Translational Research
• Ultrasensitive PCR and NGS assays for tissue and liquid biopsy applications
• Proprietary enrichment technology to increase sensitivity and lower sequencing requirements
• Comprehensive solutions for mutation, CNV, and fusion analysis
• Custom assays with a pathway to clinical trial application and CDx
The PMWC 2022 Clinical & Research Tools Showcase will provide a 15-minute time slot for selected companies in this space. The Clinical & Research Tools is a showcase for innovative technologies that are used for the analysis of genetic variation and function, helping to advance breakthroughs in genetic health, rare disease conditions on individuals of all ages, complex diseases and cancer care. Next-generation sequencing (NGS) and microarray technologies empower rapidly evolving genomic revolution.